I could see it for some of the smaller indications, but for something like cancer. If we are as effective in stopping metastasis as we appear to be, every oncologist in the world will know and will prescribe Leronlimab.

For indication where there is competition, like rheumatoid arthritis, I could see an advertising campaign being viable.